Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Greenfire Bio
BioCentury | Jan 26, 2023
Management Tracks
Juvena hires three new senior executives
Plus: new CEO at ClostraBio, and updates from Cambrian and Pliant
BioCentury | Nov 16, 2022
Product Development
MGFB: vaccinating against tumor antigen escape
The Greenfire Bio subsidiary is developing xenogenic tumor antigen libraries delivered via engineered viruses
BioCentury | Nov 9, 2022
Regulation
Nov. 8 Quick Takes: FDA request could extend review of BioMarin’s hemophilia therapy
Plus Sanofi’s latest AI deal taps Insilico and updates from Kronos, Marinus and more
Items per page:
1 - 3 of 3